Search

Find what you’re looking for

1779 results 'Active' in All Content

Nouryon to double capacity of Kromasil® chromatography media in Sweden to meet growing demand for peptide-based diabetes and obesity treatments

Nouryon today announced the expansion of its Kromasil® chromatography media manufacturing facility in Bohus, Sweden. Construction will begin in early 2025, and the start of production is expected in early 2027. This expansion will double the facility’s capacity to meet the growing global demand for peptide-based drugs in the GLP-1 receptor agonist class. Kromasil® chromatography media, a key product in the Company's Consumer & Life Sciences segment, plays a crucial role for purifying novel peptide-based pharmaceuticals, including treatments for type 2 diabetes and obesity.

https://www.nouryon.com/news-and-events/news-overview/2025/nouryon-to-double-capacity-of-kromasil-chromatography-media-in-sweden-to-meet-growing-demand-for-peptide-based-diabetes-and-obesity-treatments/

We respect your privacy.

We use essential and non-essential cookies to provide, secure, analyze and improve our services. Click 'Agree' to accept or learn more about our Cookie Policy and edit your preferences. 

You can change settings at any time.

Edit